Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials – MedCity News
Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development, but it’s no picnic for…
Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development, but it’s no picnic for…
As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His tenure there came as Dupixent…
Newswise — CHARLOTTE, N.C. — Advocate Health is reinforcing its role as a national leader in oncology care and artificial…
In a cell, the nucleus and related genetic material are housed inside a double-layered membrane. Scientists previously thought this nuclear…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…
Alzheimer’s disease can be treated with antibodies that clear away plaques of amyloid protein, but these medicines require frequent dosing…
Models are out, molecules are in as AI startups sprint to clinic Endpoints News Source link
Home to leading hospitals, universities and health-focused incubators, Houston is a breeding ground for innovative medical technology and breakthroughs that…